Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary EndpointBusiness Wire • 10/18/25
Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 CongressBusiness Wire • 09/22/25
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal CancerBusiness Wire • 08/19/25
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/06/25
Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth ConferenceBusiness Wire • 07/29/25
Is the Options Market Predicting a Spike in Delcath Systems Stock?Zacks Investment Research • 07/17/25
Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should KnowZacks Investment Research • 06/04/25
Wall Street Analysts Predict a 48.69% Upside in Delcath Systems (DCTH): Here's What You Should KnowZacks Investment Research • 05/28/25
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor ConferenceBusiness Wire • 05/15/25
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast CancerBusiness Wire • 04/28/25